Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 692 million compared to CNY 495.24 million a year ago. Revenue was CNY 692 million compared to CNY 495.24 million a year ago.

Net income was CNY 171.08 million compared to CNY 128.9 million a year ago. Basic earnings per share from continuing operations was CNY 1.53 compared to CNY 1.15 a year ago. Diluted earnings per share from continuing operations was CNY 1.53 compared to CNY 1.15 a year ago.